Joachim Kuhnke

This inventor holds 32 USPTO granted patents and 12 published patent applications, plus 2 CIPO patents and 16 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Bayer Pharma Aktiengesellschaft, Schering Aktiengesellschaft, Bayer Aktiengesellschaft. Active years: 1998-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joachim Kuhnke. Retrieved from https://idiyas.com/inventor/joachim-kuhnke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 (Patent Applications = 12)

% Patents Active = 43.8

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 16 (Patent Applications = 25)

Average Co-Inventor Count = 7.8

ph-index = 4

Forward Citations = 86(Granted Patents)

Location History:

Berlin, DE (1998 - 2004)
Porsdam, DE (2005)
Postdam, DE (2008 - 2009)
Potsdam, DE (2005 - 2021)
Leverkusen, DE (2022 - 2024)

Company Filing History:

13 out of 387

Bayer Pharma Aktiengesellschaft

patents

11 out of 1,409

Schering Aktiengesellschaft

patents

8 out of 12,268

Bayer Aktiengesellschaft

patents

4. 8 out of 486

The Broad Institute, Inc.

patents

5. 3 out of 721

Bayer Intellectual Property Gmbh

patents

6. 2 out of 192

Bayer Schering Pharma Ag

patents

7. 1 out of 1

Schering Akitengesellschaft

patent

8. 2 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2024

Loading Chart...

Areas of Expertise:

Indole Derivatives

Benzimidazole Compounds

Steroid Derivatives

Macrocyclic Compounds

BUB1 Inhibitors

EP4 Antagonists

Pyrimidines

Pharmaceutical Agents

Medicinal Chemistry

Triazoleazepines

Hormonal Derivatives

Chemical Synthesis

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12152041 - Macrocyclic fluorine substituted indole derivatives (2024-11-26),

2. 11891404 - Substituted macrocyclic indole derivatives (2024-02-06),

3. 11492358 - Macrocyclic indole derivatives (2022-11-08),

4. 11478451 - Macrocyclic chlorine substituted indole derivatives (2022-10-25),

5. 11447504 - Macrocyclic chlorine substituted indole derivatives (2022-09-20),

6. 11440923 - Substituted macrocyclic indole derivatives (2022-09-13),

7. 11401278 - Macrocyclic indole derivatives (2022-08-02),

8. 11286263 - Macrocyclic fluorine substituted indole derivatives (2022-03-29),

9. 10981932 - Macrocyclic indole derivatives (2021-04-20),

10. 10350206 - Benzyl substituted indazoles as BUB1 inhibitors (2019-07-16),

11. 9890147 - 2,3-benzodiazepines (2018-02-13),

12. 9708311 - Benzimidazole derivatives as EP4 antagonists (2017-07-18),

13. 9663523 - BET protein-inhibiting 5-aryltriazoleazepines (2017-05-30),

14. 9034856 - 17-(1'propenyl)-17-3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative (2015-05-19),

15. 8987239 - 19-nor-steroid derivatives with a 15α,16α-methylene group and a saturated 17,17-spirolactone ring, use thereof, and medicaments containing said derivatives (2015-03-24),

Title: The Innovative Mind of Joachim Kuhnke

Introduction: Joachim Kuhnke is a pioneering inventor hailing from Potsdam, Germany, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Joachim Kuhnke holds several patents in various technological domains, showcasing his versatility and ingenuity in creating novel solutions to complex problems.

Career Highlights: Throughout his illustrious career, Joachim Kuhnke has consistently pushed the boundaries of innovation, with his inventions revolutionizing industries and improving the lives of many around the world.

Collaborations: Joachim Kuhnke has collaborated with leading research institutions, universities, and tech companies, harnessing collective expertise to bring his visionary ideas to life and make a lasting impact on society.

Conclusion: Joachim Kuhnke stands as a testament to the power of innovation and the transformative potential of human creativity, leaving an indelible mark on the world of technology and beyond.

Profile summary based on public USPTO records.